Moderate Evidence
Research Overview
Thymalin Research for Age-Related Immune Decline
An evidence-based overview of research examining Thymalin in the context of age-related immune decline. This page synthesizes findings from peer-reviewed literature.
Research Summary
Russian longitudinal studies from the Khavinson laboratory report reduced mortality in elderly receiving Thymalin over 6-8 years. These findings suggest potential geroprotective effects but methodology and controls do not meet current Western trial standards.
Referenced Studies
Click any PMID to view the full study on PubMed.
Other Peptides Studied for Age-Related Immune Decline
Important Disclaimer
This page summarizes research findings and does not constitute medical advice. Thymalin may have regulatory approval for some indications but should only be used under qualified medical supervision. Always consult a healthcare provider before making health decisions.